Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
News: Latest News
Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
All NewsEconomyCurrencies & ForexEconomic EventsCryptocurrenciesCybersecurityPress Releases

EMEA Morning Briefing : Fed's Surprise Hawkish -2-

06/17/2021 | 12:31am EDT

CureVac NV said Wednesday its experimental Covid-19 vaccine was 47% effective against the disease in an interim analysis of a large clinical trial, a disappointing outcome likely to dim the shot's prospects for wider use.

The setback could hinder vaccination campaigns in Europe because the German company has a contract with the European Commission to supply up to 405 million doses. CureVac has struck partnerships with big pharmaceutical companies GlaxoSmithKline PLC and Novartis AG to help make doses.

Israel-Hamas Tensions High as Gaza Militants Launch More Flaming Balloons

TEL AVIV-Palestinian militants in Gaza launched more flaming balloons into Israel on Wednesday, as a new round of violence between Israel and Hamas entered a second day and threatened to trigger another conflict.

Little-known militant groups in Gaza claimed responsibility for the arson attacks, which ignited four fires in agricultural zones in southern Israel, according to Israel's Fire and Rescue Authority.

Regeneron's Antibody Drug Cuts Risk of Death in Some Covid-19 Patients

An antibody treatment developed by Regeneron Pharmaceuticals Inc. has been shown to significantly cut the risk of death among certain hospitalized Covid-19 patients, raising hopes for a valuable new tool for tackling severe cases.

A large U.K. trial involving nearly 10,000 patients showed that administering REGEN-COV on top of usual care reduced the risk of dying by a fifth among hospitalized coronavirus patients who hadn't produced antibodies to the virus. The drug had no effect among patients who had already produced antibodies.

Write to paul.larkins@dowjones.com

Expected Major Events for Thursday

04:30/NED: May Unemployment

06:00/EU: May New Passenger Car Registrations in Europe statistics (EU27 + EFTA3)

06:00/SWI: May Trade Balance

07:00/SVK: May Harmonized CPI

07:00/AUT: May CPI

07:00/SPN: Apr Trade Balance

07:30/SWE: 1Q Financial accounts

07:30/SWI: Swiss National Bank monetary policy assessment

08:00/ITA: Apr Foreign Trade EU

08:00/NOR: Norges Bank monetary policy decision and presentation of Monetary Policy Report

09:00/MLT: May Harmonised CPI

09:00/EU: May Harmonised CPI

09:00/EU: Apr Construction output

11:00/TUR: Turkish interest rate decision

All times in GMT. Powered by Kantar Media and Dow Jones.

Write to us at newsletters@dowjones.com

We offer an enhanced version of this briefing that is optimized for viewing on mobile devices and sent directly to your email inbox. If you would like to sign up, please go to https://newsplus.wsj.com/subscriptions.

This article is a text version of a Wall Street Journal newsletter published earlier today

(END) Dow Jones Newswires

06-17-21 0030ET

Latest news "Economy & Forex"
12:36pBritain believes Iran attacked Israeli-managed tanker off Oman
RE
12:23pBOX OFFICE : 'Jungle Cruise' Docks With $34 Million in Theaters, $30 Million on Disney Plus
RE
12:06pAllianz cooperating as DOJ probes Structured Alpha Funds
RE
11:38aUK says 'highly likely' Iran attacked tanker off Oman
RE
11:16aZoom reaches $85 million settlement of lawsuit over user privacy, 'Zoombombing'
RE
11:05aAirbus production plans expose strategy rift with engine makers
RE
10:53aEgypt's president sisi agreed in meeting with algeria's foreign minster on full support for tunisian president - egyptian presidency
RE
10:53aEgypt, Algeria agree on full support for Tunisian president - statement
RE
10:31aU.S. senators make final tweaks to infrastructure bill, expect passage this week
RE
09:38aIndonesia extends COVID-19 restrictions for outside Java -local media
RE
Latest news "Economy & Forex"